BICO logo

BICO Group AB (publ) Stock Price

OM:BICO Community·SEK 1.3b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 16 Fair Values set on narratives written by author

BICO Share Price Performance

SEK 18.18
-14.98 (-45.17%)
SEK 30.00
Fair Value
SEK 18.18
-14.98 (-45.17%)
39.4% undervalued intrinsic discount
SEK 30.00
Fair Value
Price SEK 18.18
AnalystLowTarget SEK 30.00

BICO Community Narratives

AnalystLowTarget·
Fair Value SEK 30 39.4% undervalued intrinsic discount

Lab Automation Risks May Dominate Near Term Yet Long Term Prospects Appear Promising

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
SEK 30
39.4% undervalued intrinsic discount
Revenue
0.24% p.a.
Profit Margin
0.11%
Future PE
13.35x
Price in 2028
SEK 0.37

Trending Discussion

Updated Narratives

BICO logo

Lab Automation Risks May Dominate Near Term Yet Long Term Prospects Appear Promising

Fair Value: SEK 30 39.4% undervalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Excellent balance sheet and good value.

1 Risk
2 Rewards

BICO Group AB (publ) Key Details

SEK 1.8b

Revenue

SEK 842.1m

Cost of Revenue

SEK 938.0m

Gross Profit

SEK 2.2b

Other Expenses

-SEK 1.3b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 18, 2026
-17.77
52.69%
-70.45%
55.1%
View Full Analysis

About BICO

Founded
2016
Employees
586
CEO
Maria Forss
WebsiteView website
www.bico.com

BICO Group AB (publ) provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Life Science Solutions, and Lab Automation. The Bioprinting segment offers 3D bioprinters and bioinks with a range of technologies for various applications, resolutions, and volume/speed requirements, as well as provides services focused on accelerating drug discovery and development. The Life Science Solutions segment supplies lab instrumentation, consumables and applications in cell culture, cell imaging, cell sorting, and sample preparation for different analytics, such as genomics, as well as offers instruments and solutions for the manufacturing of diagnostics, as well as consumables. The Lab Automation segment provides the proprietary and hardware-agnostic Green Button Go Suite software for connected workflows, as well as automation technology integration, and consulting and engineering services to design, build, and install automated laboratory systems. In addition, the company offers a range of services and consumables such as reagents, bioinks, plates, and tissue models. It serves pharma and biopharma, biotech, diagnostics, academia and research, and cosmetic industries. The company offers its products through sales organizations, as well as through distributor network. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. BICO Group AB (publ) was incorporated in 2016 and is headquartered in Gothenburg, Sweden.

Recent BICO News & Updates

Little Excitement Around BICO Group AB (publ)'s (STO:BICO) Revenues

Dec 02
Little Excitement Around BICO Group AB (publ)'s (STO:BICO) Revenues

Recent updates

No updates